Company intelligence / Profile preview

Incepta Pharmaceuticals Ltd.

Ownership: Private
Employees: ~10000
Development stage: Commercial

Overview

Incepta Pharmaceuticals has multiple approved products in Bangladesh and exports to over 100 countries. Their portfolio includes biosimilars, vaccines, and various pharmaceutical products across multiple therapeutic areas.

Therapeutic areas: HematologyEndocrinologyImmunologyInfectious Diseases
Modalities: BiosimilarsMonoclonal antibodiesVaccinesSmall moleculesHormonesColony-stimulating factorsInterferons
Industry: Biotech

Drug pipeline

16 assets

rabies vaccine (Incepta Pharmaceuticals Ltd.)

Approved

15 more assets in the full pipeline.

Request access →

Partnerships

Bill & Melinda Gates FoundationClinton Health Access Initiative (CHAI)USAIDMarie Stopes InternationalIVIPATHImperial College of LondonICDDR,BOxford UniversityBioengineeringGerman AMS Technology

Beyond the preview

Go deeper on Incepta Pharmaceuticals Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Incepta Pharmaceuticals Ltd..

Explore the full profile